Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.93 USD | -1.87% |
|
+0.79% | +62.23% |
Evolution of the average Target Price on ARS Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering ARS Pharmaceuticals, Inc.
Leerink Partners | |
William Blair & Co. | |
Wedbush | |
SVB Securities LLC | |
Stifel Nicolaus | |
Goldman Sachs | |
HC Wainwright | |
SVB Leerink | |
JonesTrading Institutional Services |
EPS Revisions
- Stock Market
- Equities
- SPRY Stock
- Consensus ARS Pharmaceuticals, Inc.